Abstract:Strokes associated with non-valvular atrial fibrillation (NVAF) are increasing as the elderly population is rapidly increasing in Japan since atrial fibrillation increases with advancing age among general population. Aging and previous stroke are well-known risk factors for ischemic stroke in patients with NVAF(1-4). In NVAFpatients with risk factors for stroke warfarin but not aspirin is indicated (3, 4). Ideal patients for the indication of warfarin might be those with risk factors for ischemic stroke and without risk factors for hemorrhagic complications. Unfortunately, reality is, however, risk factors for ischemic stroke and major hemorrhage, especially intracranial hemorrhage (ICH), overlap in many NVAF patients (5-8). That is, aging, history of stroke and hypertension are risk factors not only for ischemic stroke but also for ICH (5-8). According to the Stroke Prevention in Atrial Fibrillation (SPAF) II Study (9), among patients older than 75 years, warfarin-assigned patients had a lower rate of ischemic stroke or systemic emboli but a higher rate of ICHthan aspirin-assigned patients, and thus the rate of all strokes, ischemic and hemorrhagic, with residual deficit was similar in patients assigned to warfarin and aspirin. However, the upper limit of the target intensity range of international normalized ratio (INR) in the SPAF II Study was 4.5, which was higher than other trials of warfarin therapy for primary stroke prevention in patients with NVAF,and the rate of major bleeding amongwarfarin-assigned patients exceeded that of the other trials (8). The SPAF III Study (10) showed that the rate of ischemic stroke and systemic embolism was low (1.9% per year), and ICH (0.9% per year) and major hemorrhage (2.4% per year) were low as well in patients with at least one risk factor (congestive heart failure, previous thrombembolism, systolic hypertension, or womenaged over 75 years), who were given warfarin with target INR 2.0-3.0. However, this study was designed essentially for primary prevention of stroke. The risk of major hemorrhage with warfarin even in the same range of INR might be higher in NVAFpatients with previous stroke because prior ischemic stroke is a firmly-linked predictor of anticoagulation-related ICH (5-7). For secondary prevention of stroke in patients with NVAF, efficacy and safety had been evaluated only in a single prospective study of the European Atrial Fibrillation Trial (EAFT) (1 1). The investigators reported the efficacy of warfarin treatment for secondary prevention with an INR range from 2.5 to 4.0 based on the risk reduction for stroke from 12% to 4% per year, although hemorrhagic complications were observed more frequently in the anticoagulation group than in the control group (hazard ratio 3.4). The INR range used in the EAFTwas inappropriately high compared with the recommended INR range for primary prevention as well as the usual INR level applied to elderly patients. Therefore, optimal intensity of warfarin to minimize hemorrhagic complications for the secondary prevention of ischemic stroke had still remained to be clarified in elderly patients with NVAF. Japanese NVAF-EmbolismSecondary Prevention Cooperative Study ( 12) was the first multi-center, prospective, randomized controlled trial to study an optimal intensity of warfarin for the secondary prevention of stroke in Japanese patients with NVAF.The results of this study demonstrated that the low intensity warfarin treatment (INR 1.5-2. 1 ) for prevention of stroke recurrence was safer than the conventional intensity treatment (INR 2.2-3.5) in the elderly. Major hemorrhagic complications occurred at a frequency of 6.6% per year in the conventionalintensity group and the incidence was significantly higher than in the low-intensity group (0% per year) , while the annual rate of ischemic stroke did not differ signifincantly between both groups (1. 1 % per year in the conventional-intensity group and 1.7% per year in the low-intensity group). Yasaka et al (13) combined the data of this study with their previously conducted National Cardiovascular Center (NCVC) NVAFSecondary Prevention Study.

Cholesterol ester concentration and corticosterone production in adrenals of the C57BL-10 and DBA-2 strains in relation to adrenal lipid depletion.

Determining Genetic Similarities And Relationships Among Cowpea Breeding Lines And Cultivars By Microsatellite Markers

Bambara Groundnut (Vigna subterranea [L.] Verdc.) Production, Utilisation and Genetic Improvement in Sub-Saharan Africa

Genome-Wide association analysis of phenotypic traits in Bambara groundnut under drought-stressed and non-stressed conditions based on DArTseq SNP

Population structure and genetic diversity analyses of common bean germplasm collections of East and Southern Africa using morphological traits and high-density SNP markers

Genetic clustering, and diversity of African panel of released common bean genotypes and breeding lines

Genetic Diversity and Population Structure of Cowpea (vigna Unguiculata L. Walp).

DArTSNPbased genetic diversity analyses in cassava (Manihot esculenta) genotypes sourced from different regions revealed high level of diversity within population

Genetic diversity and population structure analysis of a diverse panel of pea (Pisum sativum)

Genetic Differentiation and Diversity Upon Genotype and Phenotype in Cowpea (vigna Unguiculata L. Walp.)

Genetic diversity and population structure of Uganda’s yam (Dioscorea spp.) genetic resource based on DArTseq

Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.

Design of a seamless gateway for Mechatrolink?

Diversity, population structure, and linkage disequilibrium among cowpea accessions

Genetic diversity and structure of a barley collection predominatly from North African region

Genetic Diversity and Population Structure Analyses of Wild Relatives and Cultivated Cowpea (Vigna unguiculata (L.) Walp.) from Senegal Using Simple Sequence Repeat Markers

Genetic diversity and population structure of Uganda cassava germplasm

Deciphering the molecular basis for photosynthetic parameters in Bambara groundnut (Vigna subterranea L. Verdc) under drought stress

Genetic diversity and population structure of groundnut (Arachis hypogaea L.) accessions using phenotypic traits and SSR markers: implications for rust resistance breeding

Exosomes – nanovesicles with possible roles in allergic inflammation

DArTSeq SNP-based genetic diversity and population structure studies among taro [(Colocasia esculenta (L.) Schott] accessions sourced from Nigeria and Vanuatu